PASCARELLA, ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 1.807
AS - Asia 1.292
EU - Europa 829
SA - Sud America 278
Continente sconosciuto - Info sul continente non disponibili 109
AF - Africa 33
OC - Oceania 4
Totale 4.352
Nazione #
US - Stati Uniti d'America 1.719
SG - Singapore 562
IT - Italia 405
CN - Cina 256
BR - Brasile 214
VN - Vietnam 166
IN - India 109
EE - Estonia 101
DE - Germania 98
HK - Hong Kong 63
BD - Bangladesh 53
CA - Canada 45
FI - Finlandia 39
GB - Regno Unito 37
NL - Olanda 34
AR - Argentina 27
MX - Messico 20
ID - Indonesia 15
FR - Francia 14
PL - Polonia 13
AT - Austria 12
CO - Colombia 12
ES - Italia 12
RU - Federazione Russa 12
JP - Giappone 11
SE - Svezia 11
IQ - Iraq 9
ZA - Sudafrica 8
CZ - Repubblica Ceca 7
EC - Ecuador 7
MA - Marocco 7
PE - Perù 6
TR - Turchia 6
CH - Svizzera 5
EG - Egitto 5
IE - Irlanda 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
KR - Corea 4
SC - Seychelles 4
UA - Ucraina 4
VE - Venezuela 4
AU - Australia 3
BE - Belgio 3
CR - Costa Rica 3
GR - Grecia 3
IL - Israele 3
JM - Giamaica 3
KZ - Kazakistan 3
LV - Lettonia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GY - Guiana 2
JO - Giordania 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PY - Paraguay 2
SA - Arabia Saudita 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CU - Cuba 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
HR - Croazia 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
LY - Libia 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 4.244
Città #
San Jose 398
Singapore 272
Ashburn 212
Dallas 145
Santa Clara 103
Council Bluffs 82
Munich 75
Bengaluru 73
Hefei 66
Beijing 64
Hong Kong 62
Phoenix 61
Ho Chi Minh City 56
Los Angeles 51
Milan 47
Boardman 34
Hanoi 32
Chicago 29
Rome 28
New York 26
Turku 22
Chandler 18
Helsinki 17
London 15
Chennai 13
Montreal 13
Amsterdam 12
Genoa 12
Rio de Janeiro 12
Seattle 12
São Paulo 12
Warsaw 12
Boston 11
Atlanta 10
Naples 10
Orem 10
Tokyo 10
West Jordan 10
Ninh Bình 9
Brooklyn 8
Buffalo 8
Haiphong 8
San Francisco 8
Washington 8
Florence 7
Gioia Tauro 7
Hải Dương 7
Mexico City 7
Miami 7
Palermo 7
Toronto 7
Bari 6
Bogotá 6
Brasília 6
Da Nang 6
Denver 6
Olomouc 6
San Nicola Manfredi 6
Taranto 6
The Dalles 6
Thái Bình 6
Tremestieri Etneo 6
Belo Horizonte 5
Cosenza 5
Lawrence 5
Manchester 5
Misterbianco 5
Princeton 5
Turin 5
Vienna 5
Yiwu 5
Assago 4
Aversa 4
Bergamo 4
Biên Hòa 4
Casalecchio di Reno 4
Columbus 4
Curitiba 4
Dublin 4
New Delhi 4
Shanghai 4
Suzano 4
Wilmington 4
Zhengzhou 4
Betim 3
Busto Arsizio 3
Bắc Giang 3
Bắc Ninh 3
Campinas 3
Carney 3
Charlotte 3
Cittanova 3
Ercolano 3
Fort Worth 3
Istanbul 3
Las Vegas 3
Manaus 3
Medellín 3
Mesa 3
Milwaukee 3
Totale 2.456
Nome #
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy 160
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 152
Vacuolated PAS‐positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy 130
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 112
Myoclonic status epilepticus in patients with juvenile myoclonic epilepsy: Case reports and review of the literature 91
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 88
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 85
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study 82
Investigating Peri-Ictal MRI Abnormalities: A Prospective Neuroimaging Study on Status Epilepticus, Seizure Clusters, and Single Seizures 79
Status epilepticus in pregnancy: a literature review and a protocol proposal 77
Peculiar CADASIL phenotype in monozygotic twins carrying a novel NOTCH3 pathogenetic variant 77
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 76
Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients: Correlations with DMTs and clinical variables 75
Provocative techniques for functional/dissociative seizure: the colored pad test – a safe and reliable procedure 73
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients 72
Fatigue in natalizumab-treated Multiple Sclerosis patients: How much is wearing-off to blame? 72
When the practice does not meet the evidence: An Italian survey on the use of antiseizure medications in routine neurosurgery practice 71
HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance 71
Do Medical Complications Impact Long-Term Outcomes in Prolonged Disorders of Consciousness? 70
Therapeutic approach to neurological manifestations of Angelman syndrome 69
The hidden link between late-onset seizures and cerebral amyloid angiopathy: A case-control study 68
Functional seizures and binge eating disorder: A cross-sectional study 65
Exploring the Effectiveness of Adjunctive Cenobamate in Focal Epilepsy: A Time-Based Analysis 64
Investigation into the casual or causal association of cerebral venous thrombosis and myelin oligodendrocyte glycoprotein antibody‑associated disease: A case report and literature review 63
Late-onset fabry disease due to the p.Phe113Leu variant: the first italian cluster of five families 61
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study 61
Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks? 60
Alien hand syndrome-like functional seizures in a patient with right temporo-parietal damage and neurocognitive disorder: a case report 58
Utility and limitations of homemade videos in differentiating functional seizures from other paroxysmal events: An Italian cohort study 56
Second-Line Medications for Women Aged 10 to 50 Years with Idiopathic Generalized Epilepsy 56
Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis 56
Seizures When Exiting a Bath: A Rare Type of Reflex Epilepsy 55
Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis 55
Brainstem Posterior Reversible Encephalopathy Syndrome in an Asymptomatic Patient. 55
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 55
Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic 53
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy 53
Anti-seizure medications in patients with renal failure undergoing dialysis: how to manage? 53
The relevance of MRI blood-sensitive sequences in the diagnostic assessment of late-onset epilepsy 52
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology 52
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 52
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 51
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy 51
De novo myoclonic status epilepticus in Alzheimer disease 49
Epilepsy in Cerebrovascular Diseases: A Narrative Review 48
Convolutional Neural Network Classification of Rest EEG Signals among People with Epilepsy, Psychogenic Non Epileptic Seizures and Control Subjects 46
Human expressive movements: The boundary between health and disease from a contaminated perspective 45
Epilepsy and migraine: a diagnostic and therapeutic challenge 45
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 45
Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site 45
Multicentre registry of brain-injured patients with disorder of consciousness: rationale and preliminary data 43
Severe hypomagnesemia mimicking acute stroke: a rare but overlooked mimic? 41
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy 41
Modern neurophysiological techniques indexing normal or abnormal brain aging 41
Repeated transcranial direct current stimulation in prolonged disorders of consciousness: A double-blind cross-over study 40
Multi-center observational study on occurrence and related clinical factors of neurogenic heterotopic ossification in patients with disorders of consciousness 39
Evidence of small fiber neuropathy in a patient with Ehlers–Danlos syndrome, hypermobility-type 38
Late-onset diplopia: an unusual presentation of posterior cortical atrophy 38
Long-term outcome of patients with disorders of consciousness with and without epileptiform activity and seizures: a prospective single centre cohort study 37
Instrumentation for TMS-EEG Experiment: ArTGen and a Custom EEG Interface 37
HEADWORK Questionnaire: Why Do We Need a New Tool to Assess Work-Related Disability in Patients With Migraine? 36
Correction to: A video of best practice recommendations for making botulinum toxin therapy safe during the COVID?19 pandemic (Neurological Sciences, (2021), 42, 9, (3937-3938), 10.1007/s10072-021-05375-z) 36
The neurological core features of the infantile-onset multisystem neurologic, endocrine, and pancreatic disease: A novel nonsense mutation in an Italian family 35
Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: A study on 233 patients 35
Myoclonus: Differential diagnosis and current management 34
Effect of mannitol bolus administration on cerebrospinal fluid pressure in patients with idiopathic intracranial hypertension: a pilot study 34
Late-onset Fabry disease due to a new (p.Pro380Leu) pathogenic variant of GLA Gene 34
null 33
Palatal tremor in a patient with prolonged vegetative state after ischemic stroke 32
Hemiparkinsonism-hemiatrophy syndrome: a long-term clinical, neurophysiological, and neuroimaging follow-up study 32
Urinary Liver-Type Fatty Acid Binding Protein as a Postoperative Marker of Acute Kidney Injury in Patients Undergoing EndovascularAortic Aneurysm Repair 32
Clinical and electroencephalographic on–off effect of amantadine in chronic non-traumatic minimally conscious state 31
Epilepsy beyond seizures: embracing a holistic perspective. Proceedings of the 2nd meeting (Episicily) of the epilepsy study group of the Italian Society of neurology 29
Neurological Causes of Dizziness and Vertigo 27
An EEG-Based Edge-AI Framework for Alzheimer's and Creutzfeldt-Jakob Disease Classification 15
Dietary Modulation of Migraine: Metabolic, Neuroinflammatory and Microbiota-Mediated Mechanisms 13
B-cell–driven relapse and anti-CD20 rescue therapy after Alemtuzumab in RRMS: case report and literature review 13
Clinical features of adolescent-onset functional motor disorders in tertiary movement disorders centers 12
Effective Surgical Management of Coexisting DNET-Related Focal Epilepsy and Epilepsy with Eyelid Myoclonia 12
Seizure and Status Epilepticus in Human Organophosphate Poisoning: A Narrative Review 10
Epilepsia partialis continua as the presenting manifestation of Creutzfeldt–Jakob disease: A video-polygraphic clinical vignette 8
Mannitol effectiveness in lowering intracranial pressure in idiopathic intracranial hypertension: A case series 4
Totale 4.352
Categoria #
all - tutte 26.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202215 0 0 0 5 4 0 0 1 2 1 2 0
2022/202379 10 0 6 6 11 6 1 5 11 14 5 4
2023/2024167 17 15 6 5 5 10 24 17 16 14 11 27
2024/2025999 97 74 39 47 32 126 43 18 72 109 117 225
2025/20262.408 135 198 267 358 236 108 269 130 288 210 151 58
2026/2027664 72 178 294 120 0 0 0 0 0 0 0 0
Totale 4.352